Rayner set to launch RayOne® at the XXXIV Congress of the ESCRS
Following the recent receipt of CE mark approval, Rayner are proud to announce the launch of RayOne®: their fully preloaded IOL injection system to be unveiled at the upcoming ESCRS in Copenhagen.
This flagship launch is the second in the pipeline of 11 new products which Rayner plan to launch over the next 3 years, a testament to Rayner’s renewed commitment to transform into one of the leading manufacturers of IOLs, all with the ambition of delivering better patient outcomes.
Latest Articles
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Update on Astigmatism Analysis
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
José Güell: Trends in Cornea Treatment
Endothelial damage, cellular treatments, human tissue, and infections are key concerns on the horizon.
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.